mouse anti 14 Search Results


93
SouthernBiotech goat anti mouse polyclonal von southern biotech
Goat Anti Mouse Polyclonal Von Southern Biotech, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti mouse polyclonal von southern biotech/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
goat anti mouse polyclonal von southern biotech - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
SouthernBiotech rat anti mouse ige
Rat Anti Mouse Ige, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti mouse ige/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
rat anti mouse ige - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

99
Bio X Cell anti pd 1
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Anti Pd 1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pd 1/product/Bio X Cell
Average 99 stars, based on 1 article reviews
anti pd 1 - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

94
Bio X Cell cp151
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Cp151, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cp151/product/Bio X Cell
Average 94 stars, based on 1 article reviews
cp151 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

96
Bio X Cell anti cd47
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Anti Cd47, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd47/product/Bio X Cell
Average 96 stars, based on 1 article reviews
anti cd47 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

94
Bio X Cell cd62l monoclonal antibody mel 14
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Cd62l Monoclonal Antibody Mel 14, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd62l monoclonal antibody mel 14/product/Bio X Cell
Average 94 stars, based on 1 article reviews
cd62l monoclonal antibody mel 14 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Cedarlane fitc conjugated anti cd62l mel 14 mab
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Fitc Conjugated Anti Cd62l Mel 14 Mab, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc conjugated anti cd62l mel 14 mab/product/Cedarlane
Average 93 stars, based on 1 article reviews
fitc conjugated anti cd62l mel 14 mab - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Bio X Cell anti pd1 rmp1 14
(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), <t>anti-CTLA-4</t> <t>+</t> <t>anti-PD-1</t> immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.
Anti Pd1 Rmp1 14, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pd1 rmp1 14/product/Bio X Cell
Average 94 stars, based on 1 article reviews
anti pd1 rmp1 14 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
Bio X Cell anti notch4 mab
a , RT-PCR of Notch1 - 4 transcripts in lung T reg and T eff cells isolated from PBS, OVA and OVA+UFP mouse groups (n=5). b , c , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of <t>Notch4</t> expression on lung T reg and T eff cells in the respective treated groups (n=15). d , Flow cytometric analysis and cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-6 or anti-IL-6R mAb (n=5). e , Flow cytometric analysis and cell frequencies of Notch4 + Helios – and Helios + lung T reg cells isolated from the respective treated groups (n=5). f , Flow cytometric analysis and cell frequencies of Notch4 expression on in vitro differentiated T reg cells derived from naive CD4 + T cells isolated from Foxp3 YFPCre , Foxp3 YFPCre Il6r Δ/Δ and Foxp3 YFPCre Stat3 Δ/Δ mice and either untreated or treated with IL-6 (n=6). g , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch4 promoter in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=6). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( b,c,f ); two-way ANOVA with Sidak’s post hoc analysis ( a,d,e,g ). *P<0.05, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.
Anti Notch4 Mab, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti notch4 mab/product/Bio X Cell
Average 92 stars, based on 1 article reviews
anti notch4 mab - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Bio X Cell anti mouse pd 1
a , RT-PCR of Notch1 - 4 transcripts in lung T reg and T eff cells isolated from PBS, OVA and OVA+UFP mouse groups (n=5). b , c , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of <t>Notch4</t> expression on lung T reg and T eff cells in the respective treated groups (n=15). d , Flow cytometric analysis and cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-6 or anti-IL-6R mAb (n=5). e , Flow cytometric analysis and cell frequencies of Notch4 + Helios – and Helios + lung T reg cells isolated from the respective treated groups (n=5). f , Flow cytometric analysis and cell frequencies of Notch4 expression on in vitro differentiated T reg cells derived from naive CD4 + T cells isolated from Foxp3 YFPCre , Foxp3 YFPCre Il6r Δ/Δ and Foxp3 YFPCre Stat3 Δ/Δ mice and either untreated or treated with IL-6 (n=6). g , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch4 promoter in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=6). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( b,c,f ); two-way ANOVA with Sidak’s post hoc analysis ( a,d,e,g ). *P<0.05, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.
Anti Mouse Pd 1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse pd 1/product/Bio X Cell
Average 93 stars, based on 1 article reviews
anti mouse pd 1 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
Bio X Cell anti mouse mhc class ii
a , RT-PCR of Notch1 - 4 transcripts in lung T reg and T eff cells isolated from PBS, OVA and OVA+UFP mouse groups (n=5). b , c , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of <t>Notch4</t> expression on lung T reg and T eff cells in the respective treated groups (n=15). d , Flow cytometric analysis and cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-6 or anti-IL-6R mAb (n=5). e , Flow cytometric analysis and cell frequencies of Notch4 + Helios – and Helios + lung T reg cells isolated from the respective treated groups (n=5). f , Flow cytometric analysis and cell frequencies of Notch4 expression on in vitro differentiated T reg cells derived from naive CD4 + T cells isolated from Foxp3 YFPCre , Foxp3 YFPCre Il6r Δ/Δ and Foxp3 YFPCre Stat3 Δ/Δ mice and either untreated or treated with IL-6 (n=6). g , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch4 promoter in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=6). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( b,c,f ); two-way ANOVA with Sidak’s post hoc analysis ( a,d,e,g ). *P<0.05, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.
Anti Mouse Mhc Class Ii, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse mhc class ii/product/Bio X Cell
Average 91 stars, based on 1 article reviews
anti mouse mhc class ii - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

Image Search Results


(A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), anti-CTLA-4 + anti-PD-1 immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.

Journal: bioRxiv

Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells

doi: 10.64898/2026.03.23.713743

Figure Lengend Snippet: (A) UMAP visualization of major cell clusters identified from single cell RNA sequencing (scRNA-seq) of NT2.5-LM breast-to-lung metastatic tumors after 3 weeks of treatment with: vehicle (V), Entinostat (E), anti-CTLA-4 + anti-PD-1 immune checkpoint inhibitors (PC), and Entinostat + anti-CTLA-4 + anti-PD-1 combination (EPC). Subclusters of MDSCs identified: G-MDSCs and M-MDSCs. (B) Iterative logistic regression analyses conducted on the major MDSC cluster comparing the Vehicle (V) and Entinostat + ICIs combination treatment (EPC). (C) Expression of Malat1 / MALAT1 in G- and M-MDSCs isolated from lung metastases of NT2.5-LM mice treated with vehicle vs. Entinostat for 3 weeks (left, n=2 from 5 pooled mice per treatment group), J774M murine MDSC-like cell line treated with Entinostat for 24 hours (middle, n=3), and human PBMC-derived MDSCs (hMDSCs) treated with Entinostat for 24 hours (right, n=3). (D) Median Fluorescence Intensity expression of Malat1 in CD45 + CD11b + MHC-II - F4/80 - Ly6G - Ly6C hi cells from lung metastases in 4T1 mice, treated with vehicle (V), Entinostat (E), and Entinostat + ICIs (EPC) for 3 weeks. (E) Expression of Malat1 in J774M cell line treated with various concentrations of various HDAC inhibitors, with corresponding targeted class and specific HDACs. One-way ANOVA for (C, E: all statistically significant with p<0.05, unless indicated as non-significant (ns)), Kruskal-Wallis test with Dunn’s correction for (D). * p<0.05, *** p< 0.001, **** p<0.0001. ENT = Entinostat; PAN = Panobinostat; BEL = Belinostat; VOR = Vorinostat; TSA = Trichostatin A; DOM = Domatinostat; CHL = Chlopynostat; PYR = Pyroxamide; SCA = Santacruzamate A; RGF = RGFP966; TMP = TMP269; SIS = SIS17.

Article Snippet: Immune checkpoint inhibitors (ICIs) used in this study: anti-CTLA-4 (BioXCell cat. #BE0131) and anti-PD-1 (BioXCell cat. #BE0146).

Techniques: Single Cell, RNA Sequencing, Expressing, Isolation, Derivative Assay, Fluorescence

a , RT-PCR of Notch1 - 4 transcripts in lung T reg and T eff cells isolated from PBS, OVA and OVA+UFP mouse groups (n=5). b , c , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of Notch4 expression on lung T reg and T eff cells in the respective treated groups (n=15). d , Flow cytometric analysis and cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-6 or anti-IL-6R mAb (n=5). e , Flow cytometric analysis and cell frequencies of Notch4 + Helios – and Helios + lung T reg cells isolated from the respective treated groups (n=5). f , Flow cytometric analysis and cell frequencies of Notch4 expression on in vitro differentiated T reg cells derived from naive CD4 + T cells isolated from Foxp3 YFPCre , Foxp3 YFPCre Il6r Δ/Δ and Foxp3 YFPCre Stat3 Δ/Δ mice and either untreated or treated with IL-6 (n=6). g , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch4 promoter in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=6). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( b,c,f ); two-way ANOVA with Sidak’s post hoc analysis ( a,d,e,g ). *P<0.05, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , RT-PCR of Notch1 - 4 transcripts in lung T reg and T eff cells isolated from PBS, OVA and OVA+UFP mouse groups (n=5). b , c , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of Notch4 expression on lung T reg and T eff cells in the respective treated groups (n=15). d , Flow cytometric analysis and cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-6 or anti-IL-6R mAb (n=5). e , Flow cytometric analysis and cell frequencies of Notch4 + Helios – and Helios + lung T reg cells isolated from the respective treated groups (n=5). f , Flow cytometric analysis and cell frequencies of Notch4 expression on in vitro differentiated T reg cells derived from naive CD4 + T cells isolated from Foxp3 YFPCre , Foxp3 YFPCre Il6r Δ/Δ and Foxp3 YFPCre Stat3 Δ/Δ mice and either untreated or treated with IL-6 (n=6). g , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch4 promoter in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=6). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( b,c,f ); two-way ANOVA with Sidak’s post hoc analysis ( a,d,e,g ). *P<0.05, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Reverse Transcription Polymerase Chain Reaction, Isolation, Fluorescence, Expressing, Generated, In Vitro, Derivative Assay, Binding Assay, Control

a - c , Flow cytometric analysis, cell frequencies and (MFI) of Notch1, 2 and 3 expression on lung T reg and T eff cells in Foxp3 YFPCre (n=5). d , Cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-1β, IL-25, IL-33, TSLP or TNF (n=5). e , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch1, 2 and 3 promoters in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=5). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( a-c ); two-way ANOVA with Sidak’s post hoc analysis ( d,e ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a - c , Flow cytometric analysis, cell frequencies and (MFI) of Notch1, 2 and 3 expression on lung T reg and T eff cells in Foxp3 YFPCre (n=5). d , Cell frequencies of Notch4 expression on OT-II + CD4 + Foxp3 + T cells generated in co-cultures with sham or OVA 323–339 +UFP-pulsed alveolar macrophages without or with IL-1β, IL-25, IL-33, TSLP or TNF (n=5). e , ChIP assays for the binding of STAT3 and control (IgG) antibodies to the Notch1, 2 and 3 promoters in lung T reg cells of OVA+UFP-treated Foxp3 YFPCre , and Foxp3 YFPCre Stat3 Δ/Δ mice (n=5). Each symbol represents one mouse. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( a-c ); two-way ANOVA with Sidak’s post hoc analysis ( d,e ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Expressing, Generated, Binding Assay, Control

a , RT-PCR analysis of Notch4 expression in CD4 Cre mice in B-cells and T-cells (n=5). b , RT-PCR analysis of Notch4 expression in Foxp3 YFPCre mice in both T reg and T eff cells (n=5). c , d , IL-4 and IFN-γ expression in lung Foxp3 + CD4 + T reg . ( c ) and Foxp3 – CD4 + T eff cells. ( d ) derived from the respectively treated Foxp3 YFPCre , CD4 Cre Notch 4 Δ/Δ and Foxp3 YFPCre Notch 4 Δ/Δ mice (n=5). e , Airway hyperresponsiveness in Foxp3 YFPCre sensitized either with PBS or OVA, then challenged with OVA+UFP following transfer of OTII + Foxp3 YFPCre or OTII + Foxp3 YFPCre Notch4 Δ/Δ iT reg cells (n=5). f , Eosinophil numbers for the respective mouse groups (n=5). g , IL-4, IL-13, IL-17 and IFNγ expression in lung Foxp3 – CD4 – T eff cells. Each symbol represents one mouse (n=5). Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( a,c,d ); One-way ANOVA with Dunnett’s post hoc analysis ( e,f ). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , RT-PCR analysis of Notch4 expression in CD4 Cre mice in B-cells and T-cells (n=5). b , RT-PCR analysis of Notch4 expression in Foxp3 YFPCre mice in both T reg and T eff cells (n=5). c , d , IL-4 and IFN-γ expression in lung Foxp3 + CD4 + T reg . ( c ) and Foxp3 – CD4 + T eff cells. ( d ) derived from the respectively treated Foxp3 YFPCre , CD4 Cre Notch 4 Δ/Δ and Foxp3 YFPCre Notch 4 Δ/Δ mice (n=5). e , Airway hyperresponsiveness in Foxp3 YFPCre sensitized either with PBS or OVA, then challenged with OVA+UFP following transfer of OTII + Foxp3 YFPCre or OTII + Foxp3 YFPCre Notch4 Δ/Δ iT reg cells (n=5). f , Eosinophil numbers for the respective mouse groups (n=5). g , IL-4, IL-13, IL-17 and IFNγ expression in lung Foxp3 – CD4 – T eff cells. Each symbol represents one mouse (n=5). Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( a,c,d ); One-way ANOVA with Dunnett’s post hoc analysis ( e,f ). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Derivative Assay

a , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre , CD4 Cre Notch4 Δ/Δ or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). b , Inflammation scores in the respective lung tissues. c , AHR in the respective mouse groups in response to methacholine. ( d , e ) serum total and OVA-specific IgE concentrations. f , g , absolute numbers of lung CD4 + T cells and eosinophils. ( h , i ) IL-13 and IL-17 expression in lung Foxp3 + CD4 + T reg ( h) , and Foxp3 – CD4 + T eff cells. ( i ). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( b - i ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments. (White bars n=15), (black bars n=5) and (grey bars n=15).

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre , CD4 Cre Notch4 Δ/Δ or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). b , Inflammation scores in the respective lung tissues. c , AHR in the respective mouse groups in response to methacholine. ( d , e ) serum total and OVA-specific IgE concentrations. f , g , absolute numbers of lung CD4 + T cells and eosinophils. ( h , i ) IL-13 and IL-17 expression in lung Foxp3 + CD4 + T reg ( h) , and Foxp3 – CD4 + T eff cells. ( i ). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( b - i ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments. (White bars n=15), (black bars n=5) and (grey bars n=15).

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Staining, Isolation, Expressing

a , scheme of the house dust mite (HDM) airway inflammation protocol. b , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). c , Inflammation scores in the respective lung tissues. d , AHR in the respective mouse groups in response to methacholine. e , serum total IgE concentrations. ( f - h ), absolute numbers of lung CD4 + T cells, neutrophils and eosinophils. i , k , IL-4, IL-13, IL-17 and IFNγ expression in lung Foxp3 + CD4 + T reg ( i ) and Foxp3 – CD4 + T eff cells ( k ). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis (c - k ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments. n=5 mice per group.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , scheme of the house dust mite (HDM) airway inflammation protocol. b , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). c , Inflammation scores in the respective lung tissues. d , AHR in the respective mouse groups in response to methacholine. e , serum total IgE concentrations. ( f - h ), absolute numbers of lung CD4 + T cells, neutrophils and eosinophils. i , k , IL-4, IL-13, IL-17 and IFNγ expression in lung Foxp3 + CD4 + T reg ( i ) and Foxp3 – CD4 + T eff cells ( k ). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis (c - k ). **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments. n=5 mice per group.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Staining, Isolation, Expressing

a , Scheme for the chronic airway inflammation mouse protocol b , Representative Sirius-Red-stained sections of lung tissues isolated from Foxp3 YFPCre or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). c , Collagen disposition measurement in the respective lung tissues. d , AHR in the respective mouse groups in response to methacholine. e , f , absolute numbers of lung CD4 + T cells and eosinophils. g , h , IL-4, IL-13, and IL-17 expression in lung Foxp3 + CD4 + T reg ( g ) and Foxp3 – CD4 + T eff cells ( h ). i , Serum OVA-specific IgE titers in the respective groups. Each symbol represents an independent sample. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( c-h). *P<0.05, ****P<0.0001. Data representative of two or three independent experiments. n=5 mice per group.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , Scheme for the chronic airway inflammation mouse protocol b , Representative Sirius-Red-stained sections of lung tissues isolated from Foxp3 YFPCre or Foxp3 YFPCre Notch4 Δ/Δ mice segregated into PBS, OVA or OVA+UFP-treated groups (200X magnification). c , Collagen disposition measurement in the respective lung tissues. d , AHR in the respective mouse groups in response to methacholine. e , f , absolute numbers of lung CD4 + T cells and eosinophils. g , h , IL-4, IL-13, and IL-17 expression in lung Foxp3 + CD4 + T reg ( g ) and Foxp3 – CD4 + T eff cells ( h ). i , Serum OVA-specific IgE titers in the respective groups. Each symbol represents an independent sample. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( c-h). *P<0.05, ****P<0.0001. Data representative of two or three independent experiments. n=5 mice per group.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Staining, Isolation, Expressing

a , Volcano plot of differential gene expression in Foxp3 YFPCre versus Foxp3 YFPCre Notch4 Δ/Δ T reg cells treated with OVA+UFP. FDR, false discovery rate; log2FC, log2(fold change). b , Enrichment pathway analysis of Hippo and Wnt pathways. c, Flow cytometric analysis and cell frequencies of Yap1 expression on lung T reg cells in the respective treated groups (n=5). d, Flow cytometric analysis and cell frequencies of β-Catenin expression on lung T reg cells in the respective treated groups (n=5). e, representative histogram, cell frequencies and MFI of phospho-Mob1 expression on lung T reg cells in the respective treated groups (light grey bar n= 4, dark grey bar n=4, light red bar n=5 and dark red bar n=4). f, representative histogram, cell frequencies and MFI of phospho-Lats1 T1079 expression on lung T reg cells in the respective treated groups (light grey bar n= 4, dark grey bar n=4, light red bar n=5 and dark red bar n=4). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( c,d ); one-way ANOVA with Dunnett’s post hoc analysis ( e,f ). ***P<0.001, ****P<0.0001.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , Volcano plot of differential gene expression in Foxp3 YFPCre versus Foxp3 YFPCre Notch4 Δ/Δ T reg cells treated with OVA+UFP. FDR, false discovery rate; log2FC, log2(fold change). b , Enrichment pathway analysis of Hippo and Wnt pathways. c, Flow cytometric analysis and cell frequencies of Yap1 expression on lung T reg cells in the respective treated groups (n=5). d, Flow cytometric analysis and cell frequencies of β-Catenin expression on lung T reg cells in the respective treated groups (n=5). e, representative histogram, cell frequencies and MFI of phospho-Mob1 expression on lung T reg cells in the respective treated groups (light grey bar n= 4, dark grey bar n=4, light red bar n=5 and dark red bar n=4). f, representative histogram, cell frequencies and MFI of phospho-Lats1 T1079 expression on lung T reg cells in the respective treated groups (light grey bar n= 4, dark grey bar n=4, light red bar n=5 and dark red bar n=4). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( c,d ); one-way ANOVA with Dunnett’s post hoc analysis ( e,f ). ***P<0.001, ****P<0.0001.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Gene Expression, Expressing

a , flow cytometric analysis and frequencies of IL13 + ILC2 (Lineage – T1/ST2 + cells) in mice of respective genotypes treated as indicated (n=5). b , c , In vitro suppression assays using ILC2 from OVA+UFP-treated Foxp3 YFPCre mice and lung T reg cells of the respective genotypes, treated as indicated (n=4) . d , GDF15 transcripts in T reg cells of Foxp3 YFPCre , Foxp3 YFPCre Notch4 Δ/Δ and Foxp3 YFPCre Ctnnb1 Δ/Δ (n=5). e , flow cytometric analysis and frequencies of GDF15 + lung T reg cells in the respective mouse genotypes treated as indicated (n=5). f , flow cytometric analysis and frequencies of IL-13 induced in naive ILC2 stimulated with IL-33, GDF15 or both (n=3). g , IL-13 expression in naive ILC2 incubated with Notch4 hi T reg cells from OVA+UFP treated mice without or with blocking GDF15 peptide (n=6). h , In vitro suppression assays using lung T reg cells and ILC2 isolated from OVA+UFP-treated Foxp3 YFPCre mice and incubated without or with GDF15 blocking peptide (n=4). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( a - e , h ); One-way ANOVA with Dunnett’s post hoc analysis ( f,g ). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , flow cytometric analysis and frequencies of IL13 + ILC2 (Lineage – T1/ST2 + cells) in mice of respective genotypes treated as indicated (n=5). b , c , In vitro suppression assays using ILC2 from OVA+UFP-treated Foxp3 YFPCre mice and lung T reg cells of the respective genotypes, treated as indicated (n=4) . d , GDF15 transcripts in T reg cells of Foxp3 YFPCre , Foxp3 YFPCre Notch4 Δ/Δ and Foxp3 YFPCre Ctnnb1 Δ/Δ (n=5). e , flow cytometric analysis and frequencies of GDF15 + lung T reg cells in the respective mouse genotypes treated as indicated (n=5). f , flow cytometric analysis and frequencies of IL-13 induced in naive ILC2 stimulated with IL-33, GDF15 or both (n=3). g , IL-13 expression in naive ILC2 incubated with Notch4 hi T reg cells from OVA+UFP treated mice without or with blocking GDF15 peptide (n=6). h , In vitro suppression assays using lung T reg cells and ILC2 isolated from OVA+UFP-treated Foxp3 YFPCre mice and incubated without or with GDF15 blocking peptide (n=4). Each symbol represents an independent sample. Numbers in flow plots indicate percentages. Error bars indicate SEM. Statistical tests: two-way ANOVA with Sidak’s post hoc analysis ( a - e , h ); One-way ANOVA with Dunnett’s post hoc analysis ( f,g ). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: In Vitro, Expressing, Incubation, Blocking Assay, Isolation

a , d , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre and Foxp3 YFPCre Notch4 Δ/Δ with either PBS or OVA+UFP, the latter either alone or supplemented with GDF15 or GDF15 blocking peptide, as indicated (200X magnification), Inflammation score for the respective mouse groups (n=10). b , e , AHR in Foxp3 YFPCre and Foxp3 YFPCre Notch4 Δ/Δ treated as indicated (n=10). c , f , Frequencies and absolute numbers of ILC2, eosinophils, IL-4, and IL-13, expression in lung Foxp3 – CD4 + T eff cells in the respective groups (n=10) g, AHR in Rora Cre and Rora Cre Il4/Il13 Δ/Δ treated as indicated (n=5). h, Frequencies and absolute numbers of eosinophils, ILC2, IL-4, and IL-13, expression in lung Foxp3 – CD4 + T eff cells in the respective groups (n=5). Error bars indicate SEM. Statistical tests. One-way ANOVA with Dunnett’s post hoc analysis. ( a,c,d,f ), two-way ANOVA with Sidak’s post hoc analysis ( b , e , g , h ); *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , d , Representative PAS-stained sections of lung tissues isolated from Foxp3 YFPCre and Foxp3 YFPCre Notch4 Δ/Δ with either PBS or OVA+UFP, the latter either alone or supplemented with GDF15 or GDF15 blocking peptide, as indicated (200X magnification), Inflammation score for the respective mouse groups (n=10). b , e , AHR in Foxp3 YFPCre and Foxp3 YFPCre Notch4 Δ/Δ treated as indicated (n=10). c , f , Frequencies and absolute numbers of ILC2, eosinophils, IL-4, and IL-13, expression in lung Foxp3 – CD4 + T eff cells in the respective groups (n=10) g, AHR in Rora Cre and Rora Cre Il4/Il13 Δ/Δ treated as indicated (n=5). h, Frequencies and absolute numbers of eosinophils, ILC2, IL-4, and IL-13, expression in lung Foxp3 – CD4 + T eff cells in the respective groups (n=5). Error bars indicate SEM. Statistical tests. One-way ANOVA with Dunnett’s post hoc analysis. ( a,c,d,f ), two-way ANOVA with Sidak’s post hoc analysis ( b , e , g , h ); *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Staining, Isolation, Blocking Assay, Expressing

a , b , Flow cytometric analysis, cell frequencies and MFI of Notch4 expression on circulating T reg cells ( a ) and T eff cells ( b ) of control and asthmatic subjects, the latter segregated for asthma severity (control: n=39; mild n=31; moderate: n=27; severe: n=11). c , flow cytometric analysis, cell frequencies and MFI of Notch4 expression on Helios + versus Helios – circulating T reg cells of control and asthmatic subjects (control: n=13; mild n=9, moderate n=14; severe: n=11). d , e , Flow cytometric analysis, cell frequencies and MFI of Yap ( d ) and β-catenin ( e ) expression on circulating T reg cells of control and severe asthmatic subjects (control n=24; mild n=15; moderate n=15; severe: n=11). f , Serum GDF15 concentrations in moderate and severe asthmatic subjects plotted as a function of Notch4 expression on circulating T reg cells (n=21). g , In vitro suppression third party CD4 + T cells (T eff ) by the Notch4 hi versus Notch4 lo T reg cells from severe asthmatics compared to T reg cells of control subjects (n=2 subjects, 3 replicates per dilution per subject). h , In vitro suppression assays of ILC2 activation using circulating Notch4 hi T reg cells of asthmatics subjects and control T reg cells of healthy controls, incubated at the indicated T reg cell:ILC2 ratios without or with GDF15 blocking peptide (n=5). i , Flow cytometric analysis of Notch4 expression in T reg cells of a healthy control and a severe asthmatic before and after treatment with anti-IL-6R mAb (n=1). Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( a - e ); simple linear regression analysis ( f ); two-way ANOVA with Sidak’s post hoc analysis ( g,h ); ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , b , Flow cytometric analysis, cell frequencies and MFI of Notch4 expression on circulating T reg cells ( a ) and T eff cells ( b ) of control and asthmatic subjects, the latter segregated for asthma severity (control: n=39; mild n=31; moderate: n=27; severe: n=11). c , flow cytometric analysis, cell frequencies and MFI of Notch4 expression on Helios + versus Helios – circulating T reg cells of control and asthmatic subjects (control: n=13; mild n=9, moderate n=14; severe: n=11). d , e , Flow cytometric analysis, cell frequencies and MFI of Yap ( d ) and β-catenin ( e ) expression on circulating T reg cells of control and severe asthmatic subjects (control n=24; mild n=15; moderate n=15; severe: n=11). f , Serum GDF15 concentrations in moderate and severe asthmatic subjects plotted as a function of Notch4 expression on circulating T reg cells (n=21). g , In vitro suppression third party CD4 + T cells (T eff ) by the Notch4 hi versus Notch4 lo T reg cells from severe asthmatics compared to T reg cells of control subjects (n=2 subjects, 3 replicates per dilution per subject). h , In vitro suppression assays of ILC2 activation using circulating Notch4 hi T reg cells of asthmatics subjects and control T reg cells of healthy controls, incubated at the indicated T reg cell:ILC2 ratios without or with GDF15 blocking peptide (n=5). i , Flow cytometric analysis of Notch4 expression in T reg cells of a healthy control and a severe asthmatic before and after treatment with anti-IL-6R mAb (n=1). Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis ( a - e ); simple linear regression analysis ( f ); two-way ANOVA with Sidak’s post hoc analysis ( g,h ); ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Expressing, Control, In Vitro, Activation Assay, Incubation, Blocking Assay

a , b , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of Notch1, 2 and 3 expression in peripheral blood T reg cells ( a ) and T eff cells ( b ) of control and asthmatic subjects, the latter segregated for asthma severity (control n=22, M.P n= 15, Mod n= 16. S.P n=11). c , Flow cytometric analysis and cell frequencies of Notch4 peripheral blood T reg cells of healthy control, food allergy (FA), eczema and FA+eczema (Control n=37, FA n= 28, Eczema n=10 and FA+Eczema n=20) d , Serum GDF15 concentrations in asthmatic subjects plotted as a function of Notch4 expression on circulating T reg cells (n=73) e , Cell frequencies of Notch4 expression in peripheral blood T reg cells in healthy subjects, allergic and non-allergic asthmatics (control = 56, non-allergic n=21, allergic n=85). Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis. ( a - c,e ); simple regression analysis ( d ). ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Journal: Nature immunology

Article Title: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma

doi: 10.1038/s41590-020-0777-3

Figure Lengend Snippet: a , b , Flow cytometric analysis, cell frequencies and mean fluorescence intensity (MFI) of Notch1, 2 and 3 expression in peripheral blood T reg cells ( a ) and T eff cells ( b ) of control and asthmatic subjects, the latter segregated for asthma severity (control n=22, M.P n= 15, Mod n= 16. S.P n=11). c , Flow cytometric analysis and cell frequencies of Notch4 peripheral blood T reg cells of healthy control, food allergy (FA), eczema and FA+eczema (Control n=37, FA n= 28, Eczema n=10 and FA+Eczema n=20) d , Serum GDF15 concentrations in asthmatic subjects plotted as a function of Notch4 expression on circulating T reg cells (n=73) e , Cell frequencies of Notch4 expression in peripheral blood T reg cells in healthy subjects, allergic and non-allergic asthmatics (control = 56, non-allergic n=21, allergic n=85). Error bars indicate SEM. Statistical tests: One-way ANOVA with Dunnett’s post hoc analysis. ( a - c,e ); simple regression analysis ( d ). ***P<0.001, ****P<0.0001. Data representative of two or three independent experiments.

Article Snippet: T reg cells at these different concentrations, 1:5, 1:10 or 1:20, from Foxp3 YFPCre mice either sham treated or treated OVA+UFP with high Notch4 expression with or without the addition of anti-Notch4 mAb (clone: HMN4–14, Bioxcell) in concentration of 10ng/ml, T reg cells from Foxp3 YFPCre Notch4 Δ/Δ , Foxp3 YFPCre Ctnnb1 Δ/Δ or Foxp3 YFPCre Yap1 Δ/Δ Wwtr1 Δ/Δ mice treated with OVA+UFP.

Techniques: Fluorescence, Expressing, Control